Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Hip joint kinematics and segment coordination variability according to pain and structural disease severity in hip osteoarthritis.

Hall M, Fox A, Bonacci J, Metcalf BR, Pua YH, Diamond LE, Allison K, Wrigley TV, Bennell KL.

J Orthop Res. 2020 Jan 25. doi: 10.1002/jor.24609. [Epub ahead of print]

PMID:
31981236
2.

Consensus recommendations on the classification, definition and diagnostic criteria of hip-related pain in young and middle-aged active adults from the International Hip-related Pain Research Network, Zurich 2018.

Reiman MP, Agricola R, Kemp JL, Heerey JJ, Weir A, van Klij P, Kassarjian A, Mosler AB, Ageberg E, Hölmich P, Warholm KM, Griffin D, Mayes S, Khan KM, Crossley KM, Bizzini M, Bloom N, Casartelli NC, Diamond LE, Di Stasi S, Drew M, Friedman DJ, Freke M, Gojanovic B, Glyn-Jones S, Harris-Hayes M, Hunt MA, Impellizzeri FM, Ishøi L, Jones DM, King MG, Lawrenson PR, Leunig M, Lewis CL, Mathieu N, Moksnes H, Risberg MA, Scholes MJ, Semciw AI, Serner A, Thorborg K, Wörner T, Dijkstra HP.

Br J Sports Med. 2020 Jan 20. pii: bjsports-2019-101453. doi: 10.1136/bjsports-2019-101453. [Epub ahead of print]

PMID:
31959678
3.

Standardised measurement of physical capacity in young and middle-aged active adults with hip-related pain: recommendations from the first International Hip-related Pain Research Network (IHiPRN) meeting, Zurich, 2018.

Mosler AB, Kemp J, King M, Lawrenson PR, Semciw A, Freke M, Jones DM, Casartelli NC, Wörner T, Ishøi L, Ageberg E, Diamond LE, Hunt MA, Di Stasi S, Reiman MP, Drew M, Friedman D, Thorborg K, Leunig M, Bizzini M, Khan KM, Crossley KM, Agricola R, Bloom N, Dijkstra HP, Griffin D, Gojanovic B, Harris-Hayes M, Heerey JJ, Hölmich P, Impellizzeri FM, Kassarjian A, Warholm KM, Mayes S, Moksnes H, Risberg MA, Scholes MJ, Serner A, van Klij P, Lewis CL.

Br J Sports Med. 2019 Dec 19. pii: bjsports-2019-101457. doi: 10.1136/bjsports-2019-101457. [Epub ahead of print]

PMID:
31857334
4.

Neuromusculoskeletal Modeling-Based Prostheses for Recovery After Spinal Cord Injury.

Pizzolato C, Saxby DJ, Palipana D, Diamond LE, Barrett RS, Teng YD, Lloyd DG.

Front Neurorobot. 2019 Dec 2;13:97. doi: 10.3389/fnbot.2019.00097. eCollection 2019. Review.

5.

Physiotherapist-led treatment for young to middle-aged active adults with hip-related pain: consensus recommendations from the International Hip-related Pain Research Network, Zurich 2018.

Kemp JL, Risberg MA, Mosler A, Harris-Hayes M, Serner A, Moksnes H, Bloom N, Crossley KM, Gojanovic B, Hunt MA, Ishøi L, Mathieu N, Mayes S, Scholes MJ, Gimpel M, Friedman D, Ageberg E, Agricola R, Casartelli NC, Diamond LE, Dijkstra HP, Di Stasi S, Drew M, Freke M, Griffin D, Heerey J, Hölmich P, Impellizzeri FM, Jones DM, Kassarjian A, Khan KM, King MG, Lawrenson PR, Leunig M, Lewis CL, Warholm KM, Reiman MP, Semciw A, Thorborg K, van Klij P, Wörner T, Bizzini M.

Br J Sports Med. 2019 Nov 15. pii: bjsports-2019-101458. doi: 10.1136/bjsports-2019-101458. [Epub ahead of print]

PMID:
31732651
6.

Reliability and Validity of Ultrasonography for Measurement of Hamstring Muscle and Tendon Cross-Sectional Area.

Kositsky A, Gonçalves BAM, Stenroth L, Barrett RS, Diamond LE, Saxby DJ.

Ultrasound Med Biol. 2020 Jan;46(1):55-63. doi: 10.1016/j.ultrasmedbio.2019.09.013. Epub 2019 Oct 25.

PMID:
31668942
7.

Deep hip muscle activation during squatting in femoroacetabular impingement syndrome.

Diamond LE, van den Hoorn W, Bennell KL, Wrigley TV, Hinman RS, O'Donnell J, Hodges PW.

Clin Biomech (Bristol, Avon). 2019 Oct;69:141-147. doi: 10.1016/j.clinbiomech.2019.07.017. Epub 2019 Jul 18.

PMID:
31351343
8.

A 12-month prospective exploratory study of muscle and fat characteristics in individuals with mild-to-moderate hip osteoarthritis.

Loureiro A, Constantinou M, Beck B, Barrett RS, Diamond LE.

BMC Musculoskelet Disord. 2019 Jun 14;20(1):283. doi: 10.1186/s12891-019-2668-z.

9.

Individuals with mild-to-moderate hip osteoarthritis exhibit altered pelvis and hip kinematics during sit-to-stand.

Higgs JP, Saxby DJ, Constantinou M, Loureiro A, Hoang H, Diamond LE, Barrett RS.

Gait Posture. 2019 Jun;71:267-272. doi: 10.1016/j.gaitpost.2019.05.008. Epub 2019 May 10.

PMID:
31108385
10.

Development of a deep neural network for automated electromyographic pattern classification.

Akhundov R, Saxby DJ, Edwards S, Snodgrass S, Clausen P, Diamond LE.

J Exp Biol. 2019 Mar 4;222(Pt 5). pii: jeb198101. doi: 10.1242/jeb.198101.

11.

Minimal medical imaging can accurately reconstruct geometric bone models for musculoskeletal models.

Suwarganda EK, Diamond LE, Lloyd DG, Besier TF, Zhang J, Killen BA, Savage TN, Saxby DJ.

PLoS One. 2019 Feb 11;14(2):e0205628. doi: 10.1371/journal.pone.0205628. eCollection 2019.

12.

A calibrated EMG-informed neuromusculoskeletal model can appropriately account for muscle co-contraction in the estimation of hip joint contact forces in people with hip osteoarthritis.

Hoang HX, Diamond LE, Lloyd DG, Pizzolato C.

J Biomech. 2019 Jan 23;83:134-142. doi: 10.1016/j.jbiomech.2018.11.042. Epub 2018 Nov 29.

PMID:
30527636
13.

Immediate effects of valgus knee bracing on tibiofemoral contact forces and knee muscle forces.

Hall M, Diamond LE, Lenton GK, Pizzolato C, Saxby DJ.

Gait Posture. 2019 Feb;68:55-62. doi: 10.1016/j.gaitpost.2018.11.009. Epub 2018 Nov 8.

PMID:
30458429
14.

Subject-specific calibration of neuromuscular parameters enables neuromusculoskeletal models to estimate physiologically plausible hip joint contact forces in healthy adults.

Hoang HX, Pizzolato C, Diamond LE, Lloyd DG.

J Biomech. 2018 Oct 26;80:111-120. doi: 10.1016/j.jbiomech.2018.08.023. Epub 2018 Aug 29.

PMID:
30213647
15.

Individuals with mild-to-moderate hip osteoarthritis have lower limb muscle strength and volume deficits.

Loureiro A, Constantinou M, Diamond LE, Beck B, Barrett R.

BMC Musculoskelet Disord. 2018 Aug 21;19(1):303. doi: 10.1186/s12891-018-2230-4.

16.

Hip joint moments during walking in people with hip osteoarthritis: a systematic review and meta-analysis.

Diamond LE, Allison K, Dobson F, Hall M.

Osteoarthritis Cartilage. 2018 Nov;26(11):1415-1424. doi: 10.1016/j.joca.2018.03.011. Epub 2018 Apr 3.

17.

Trunk, pelvis and hip biomechanics in individuals with femoroacetabular impingement syndrome: Strategies for step ascent.

Diamond LE, Bennell KL, Wrigley TV, Hinman RS, Hall M, O'Donnell J, Hodges PW.

Gait Posture. 2018 Mar;61:176-182. doi: 10.1016/j.gaitpost.2018.01.005. Epub 2018 Jan 11.

PMID:
29353742
18.

Squatting Biomechanics in Individuals with Symptomatic Femoroacetabular Impingement.

Diamond LE, Bennell KL, Wrigley TV, Hinman RS, Oʼdonnell J, Hodges PW.

Med Sci Sports Exerc. 2017 Aug;49(8):1520-1529. doi: 10.1249/MSS.0000000000001282.

PMID:
28709152
19.

A systematic review and evidence synthesis of qualitative studies to identify primary care clinicians' barriers and enablers to the management of osteoarthritis.

Egerton T, Diamond LE, Buchbinder R, Bennell KL, Slade SC.

Osteoarthritis Cartilage. 2017 May;25(5):625-638. doi: 10.1016/j.joca.2016.12.002. Epub 2016 Dec 7. Review.

20.

Coordination of deep hip muscle activity is altered in symptomatic femoroacetabular impingement.

Diamond LE, Van den Hoorn W, Bennell KL, Wrigley TV, Hinman RS, O'Donnell J, Hodges PW.

J Orthop Res. 2017 Jul;35(7):1494-1504. doi: 10.1002/jor.23391. Epub 2016 Aug 28.

21.

Isometric and isokinetic hip strength and agonist/antagonist ratios in symptomatic femoroacetabular impingement.

Diamond LE, Wrigley TV, Hinman RS, Hodges PW, O'Donnell J, Takla A, Bennell KL.

J Sci Med Sport. 2016 Sep;19(9):696-701. doi: 10.1016/j.jsams.2015.10.002. Epub 2015 Oct 22.

PMID:
26526760
22.

Hip joint biomechanics during gait in people with and without symptomatic femoroacetabular impingement.

Diamond LE, Wrigley TV, Bennell KL, Hinman RS, O'Donnell J, Hodges PW.

Gait Posture. 2016 Jan;43:198-203. doi: 10.1016/j.gaitpost.2015.09.023. Epub 2015 Oct 9.

PMID:
26475761
23.

Physical impairments and activity limitations in people with femoroacetabular impingement: a systematic review.

Diamond LE, Dobson FL, Bennell KL, Wrigley TV, Hodges PW, Hinman RS.

Br J Sports Med. 2015 Feb;49(4):230-42. doi: 10.1136/bjsports-2013-093340. Epub 2014 Sep 22. Review.

PMID:
25246442
24.

Pharmacokinetics, pharmacodynamics, and metabolism of triethylenetetramine in healthy human participants: an open-label trial.

Lu J, Poppitt SD, Othman AA, Sunderland T, Ruggiero K, Willett MS, Diamond LE, Garcia WD, Roesch BG, Cooper GJ.

J Clin Pharmacol. 2010 Jun;50(6):647-58. doi: 10.1177/0091270009349379. Epub 2010 Feb 9.

PMID:
20145262
25.

An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.

Diamond LE, Earle DC, Heiman JR, Rosen RC, Perelman MA, Harning R.

J Sex Med. 2006 Jul;3(4):628-638. doi: 10.1111/j.1743-6109.2006.00268.x.

PMID:
16839319
26.

Progress in xenotransplantation.

Diamond LE.

Expert Opin Investig Drugs. 1999 May;8(5):609-23.

PMID:
15992119
30.

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY.

Ann N Y Acad Sci. 2003 Jun;994:96-102.

PMID:
12851303
31.

Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate.

Diamond LE, Byrne GW, Schwarz A, Davis TA, Adams DH, Logan JS.

Transplantation. 2002 Jun 15;73(11):1780-7.

PMID:
12085001
32.

Evaluation of different alpha-Galactosyl glycoconjugates for use in xenotransplantation.

Byrne GW, Schwarz A, Fesi JR, Birch P, Nepomich A, Bakaj I, Velardo MA, Jiang C, Manzi A, Dintzis H, Diamond LE, Logan JS.

Bioconjug Chem. 2002 May-Jun;13(3):571-81.

PMID:
12009948
33.

Endothelial function in pigs transgenic for human complement regulating factor.

Warnecke G, Severson SR, Ugurlu MM, Taner CB, Logan JS, Diamond LE, Miller VM, McGregor CG.

Transplantation. 2002 Apr 15;73(7):1060-7.

PMID:
11965032
34.

The effect of anti-alphaGal antibody removal with immunoabsorption and splenectomy on CD46 transgenic kidney xenograft survival.

Dean PG, Cohen AJ, Dalla Valle H, Grande JP, Diamond LE, Byrne GW, Logan JS, McGregor CG, Stegall MD.

Transplant Proc. 2001 Feb-Mar;33(1-2):721-2. No abstract available.

PMID:
11267038
35.

A human CD46 transgenic pig model system for the study of discordant xenotransplantation.

Diamond LE, Quinn CM, Martin MJ, Lawson J, Platt JL, Logan JS.

Transplantation. 2001 Jan 15;71(1):132-42.

PMID:
11211178
36.

The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.

Lin SS, Hanaway MJ, Gonzalez-Stawinski GV, Lau CL, Parker W, Davis RD, Byrne GW, Diamond LE, Logan JS, Platt JL.

Transplantation. 2000 Dec 27;70(12):1667-74.

PMID:
11152095
37.

Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.

Chong AS, Ma L, Yin D, Shen J, Blinder L, XiuLong X, Williams JW, Byrne G, Diamond LE, Logan JS.

Xenotransplantation. 2000 Nov;7(4):275-83.

PMID:
11081762
38.

The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants.

Lau CL, Daggett WC, Yeatman MF, Chai P, Lin SS, Lodge AJ, Chen EP, Diamond LE, Byrne GW, Logan JS, Parker W, Platt JL, Davis RD.

J Thorac Cardiovasc Surg. 2000 Jul;120(1):29-38.

39.

CD46 transgene expression in pig peripheral blood mononuclear cells does not alter their susceptibility to measles virus or their capacity to downregulate endogenous and transgenic CD46.

Schneider-Schaulies J, Martin MJ, Logan JS, Firsching R, ter Meulen V, Diamond LE.

J Gen Virol. 2000 Jun;81(Pt 6):1431-8.

PMID:
10811926
40.

Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus.

Levy MF, Crippin J, Sutton S, Netto G, McCormack J, Curiel T, Goldstein RM, Newman JT, Gonwa TA, Banchereau J, Diamond LE, Byrne G, Logan J, Klintmalm GB.

Transplantation. 2000 Jan 27;69(2):272-80.

PMID:
10670638
41.

Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates.

Chen RH, Naficy S, Logan JS, Diamond LE, Adams DH.

Xenotransplantation. 1999 Aug;6(3):194-200.

PMID:
10503786
42.

High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron 1.

Tone M, Diamond LE, Walsh LA, Tone Y, Thompson SA, Shanahan EM, Logan JS, Waldmann H.

J Biol Chem. 1999 Jan 8;274(2):710-6.

43.

Role of CD46 in measles virus infection in CD46 transgenic mice.

Blixenkrone-Møller M, Bernard A, Bencsik A, Sixt N, Diamond LE, Logan JS, Wild TF.

Virology. 1998 Sep 30;249(2):238-48.

44.

The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.

Lin SS, Weidner BC, Byrne GW, Diamond LE, Lawson JH, Hoopes CW, Daniels LJ, Daggett CW, Parker W, Harland RC, Davis RD, Bollinger RR, Logan JS, Platt JL.

J Clin Invest. 1998 Apr 15;101(8):1745-56.

45.

Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation.

McCurry KR, Parker W, Cotterell AH, Weidner BC, Lin SS, Daniels LJ, Holzknecht ZE, Byrne GW, Diamond LE, Logan JS, Platt JL.

Hum Immunol. 1997 Dec;58(2):91-105.

PMID:
9475338
46.

The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants.

Lin SS, Kooyman DL, Daniels LJ, Daggett CW, Parker W, Lawson JH, Hoopes CW, Gullotto C, Li L, Birch P, Davis RD, Diamond LE, Logan JS, Platt JL.

Transpl Immunol. 1997 Sep;5(3):212-8.

PMID:
9402688
47.

Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium.

Diamond LE, McCurry KR, Martin MJ, McClellan SB, Oldham ER, Platt JL, Logan JS.

Transplantation. 1996 Apr 27;61(8):1241-9.

PMID:
8610425
48.

Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury.

McCurry KR, Diamond LE, Kooyman DL, Byrne GW, Martin MJ, Logan JS, Platt JL.

Transplant Proc. 1996 Apr;28(2):758. No abstract available.

PMID:
8623384
49.

Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement.

Diamond LE, McCurry KR, Oldham ER, Tone M, Waldmann H, Platt JL, Logan JS.

Transpl Immunol. 1995 Dec;3(4):305-12.

PMID:
8665149
50.

Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.

McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL.

Transplantation. 1995 Apr 27;59(8):1177-82.

PMID:
7537395

Supplemental Content

Loading ...
Support Center